Atrial Natriuretic Peptide (ANP) (1-28), human, porcine

Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.

產品編號	RP11927
規格	0.5 mg 大單詢價
數量
價格	￥900


聯系我們

產品概述

Synonyms	ANP (1-28), human, porcineANP(1-28)
Description	Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.
Sequence	{SER}{LEU}{ARG}{ARG}{SER}{SER}{CYS}{PHE}{GLY}{GLY}{ARG}{MET} {ASP}{ARG}{ILE}{GLY}{ALA}{GLN}{SER}{GLY}{LEU}{GLY}{CYS}{ASN} {SER}{PHE}{ARG}{TYR}
Sequence Shortening	SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: 7-23)
Molecular Formula	C₁₂₇H₂₀₃N₄₅O₃₉S3
Disulfide Bridge	Cys7-Cys23
Molecular Weight	3080.5

產品屬性

Purity	> 95%
Solubility	Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents.
Form	Lyophilized
Storage	Store at -20°C. Keep tightly closed. Store in a cool dry place.